These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26392851)

  • 1. Role of Pharmacovigilance in India: An overview.
    Suke SG; Kosta P; Negi H
    Online J Public Health Inform; 2015; 7(2):e223. PubMed ID: 26392851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacovigilance in India in Comparison With the USA and European Union: Challenges and Perspectives.
    Jose J; Rafeek NR
    Ther Innov Regul Sci; 2019 Nov; 53(6):781-786. PubMed ID: 30554527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacovigilance in oncology: evaluation of current practice and future perspectives.
    Baldo P; De Paoli P
    J Eval Clin Pract; 2014 Oct; 20(5):559-69. PubMed ID: 24909067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Pharmacovigilance System in India and Paradigm of Pharmacovigilance Research: An Overview.
    Singh P; Vaishnav Y; Verma S
    Curr Drug Saf; 2023; 18(4):448-464. PubMed ID: 36200243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role and Responsibilities of Various Stakeholders in Pharmacovigilance (PV).
    Phougat P; Beniwal M; Kapoor G; Aggarwal N; Kumari A; Sharma R; Chopra H; Sharma R; Kamal MA
    Curr Drug Saf; 2024 Feb; ():. PubMed ID: 38318830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities and challenges of pharmacovigilance in special populations: a narrative review of the literature.
    Li Y; Wu Y; Jiang T; Xing H; Xu J; Li C; Ni R; Zhang N; Xiang G; Li L; Li Z; Gan L; Liu Y
    Ther Adv Drug Saf; 2023; 14():20420986231200746. PubMed ID: 37780667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacovigilance in India, Uganda and South Africa with reference to WHO's minimum requirements.
    Maigetter K; Pollock AM; Kadam A; Ward K; Weiss MG
    Int J Health Policy Manag; 2015 Mar; 4(5):295-305. PubMed ID: 25905480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety reporting through a comprehensive and pragmatic pharmcovigilance process for India and emerging markets: an industry perspective.
    Swamy S; Mourya M; Kadhe G; Mane A; Sawant S
    Expert Opin Drug Saf; 2015; 14(9):1409-20. PubMed ID: 26292785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review.
    Makhene NL; Steyn H; Vorster M; Lubbe MS; Burger JR
    Ther Adv Drug Saf; 2023; 14():20420986221143272. PubMed ID: 36713000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reactions: trends in a tertiary care hospital.
    Rehan HS; Chopra D; Sah RK; Mishra R
    Curr Drug Saf; 2012 Nov; 7(5):384-8. PubMed ID: 23150923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacovigilance in Israel - tools, processes, and actions.
    Schwartzberg E; Berkovitch M; Dil Nahlieli D; Nathan J; Gorelik E
    Isr J Health Policy Res; 2017 Aug; 6(1):29. PubMed ID: 28760141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacovigilance in India: Present Scenario and Future Challenges.
    Kalaiselvan V; Srivastava S; Singh A; Gupta SK
    Drug Saf; 2019 Mar; 42(3):339-346. PubMed ID: 30269244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future.
    Alomar M; Tawfiq AM; Hassan N; Palaian S
    Ther Adv Drug Saf; 2020; 11():2042098620938595. PubMed ID: 32843958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines.
    Hartford CG; Petchel KS; Mickail H; Perez-Gutthann S; McHale M; Grana JM; Marquez P
    Drug Saf; 2006; 29(8):657-73. PubMed ID: 16872240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Veterinary pharmacovigilance in India: A need of hour.
    Kumar R; Kalaiselvan V; Verma R; Kaur I; Kumar P; Singh GN
    Indian J Pharmacol; 2017; 49(1):2-3. PubMed ID: 28458414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring the manufacturing and quality of medicines: a fundamental task of pharmacovigilance.
    Sardella M; Belcher G; Lungu C; Ignoni T; Camisa M; Stenver DI; Porcelli P; D'Antuono M; Castiglione NG; Adams A; Furlan G; Grisoni I; Hall S; Boga L; Mancini V; Ciuca M; Chonzi D; Edwards B; Mangoni AA; Tuccori M; Prokofyeva E; De Gregorio F; Bertazzoli Grabinski Broglio M; van Leeuwen B; Kruger P; Rausch C; Le Louet H
    Ther Adv Drug Saf; 2021; 12():20420986211038436. PubMed ID: 34394910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge, Attitude, and Practices regarding Pharmacovigilance and Adverse Drug Reaction reporting among Dental Students in a Teaching Hospital, Jodhpur, India: A Cross-sectional Study.
    Chhabra KG; Sharma A; Chhabra C; Reddy JJ; Deolia SG; Mittal Y
    J Contemp Dent Pract; 2017 Oct; 18(10):964-969. PubMed ID: 28989138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health Professionals' Knowledge, Attitudes and Practices about Pharmacovigilance in India: A Systematic Review and Meta-Analysis.
    Bhagavathula AS; Elnour AA; Jamshed SQ; Shehab A
    PLoS One; 2016; 11(3):e0152221. PubMed ID: 27010447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of Drug Safety During Pregnancy: Insight in Current International Activities, Future Intentions and Need for Support of National Pharmacovigilance Centres.
    Kant A; de Vries L; Rolfes L
    Drug Saf; 2019 Jan; 42(1):35-43. PubMed ID: 30284215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.